Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.
Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, Kim WR, Gores GJ, Roberts RO, Olson JE, Therneau TM, Roberts LR.
Chaiteerakij R, et al. Among authors: gores gj.
Hepatology. 2013 Feb;57(2):648-55. doi: 10.1002/hep.26092. Epub 2012 Dec 12.
Hepatology. 2013.
PMID: 23055147
Free PMC article.